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Examples of tubulocystic carcinoma of the kidney were intro-
duced in an abstract presented at the Annual Meeting of the United
States and Canada Academy of Pathology1 and also in the Armed
Forces Institute of Pathology Atlas of Tumor Pathology, Series III, in
1994.2 However, the morphological features of this rare distinctive
renal tumor were described in 1955 byMasson, who designated the
lesion a “Bellinian epithelioma” because he regarded it as
a neoplasm originating in the collecting ducts of Bellini. The ﬁrst
detailed report of the clinical and pathological details of tubulo-
cystic carcinoma were published in 1997.3 The authors described
the neoplasm as a “low-grade mucinous tubulocystic renal carci-
noma of possible collecting duct origin”. The cases were initially
considered to be derived from the collecting duct; however, since
those reported tumors were of a low-grade malignancy, the
behavior of which signiﬁcantly differed from the classical highly
aggressive collecting duct carcinomas, the term “low-grade col-
lecting duct carcinoma” was coined for this peculiar renal tumor.
Thereafter, with more cases showing similar clinical and path-
ological features, the name of the neoplasm was designated
“tubulocystic carcinoma” to denote the speciﬁc morphology.4e8 To
date, more than 50 cases have been reported. A review of the
literature showed a male predominance (of around 7:1) with
patient ages ranging from 34 years to 74 years. Tumor sizes range
from 0.3 cm to 17 cm, but most are small and discovered inciden-
tally. Tumors tend to present in a low stage (pT1a) and behave
indolently. However, sarcomatoid change,9 and metastases to
lymph nodes, lungs, and brain were reported.7y, Taipei Veterans General
aiwan.
ciation. Published by Elsevier Taiw2. Pathology
Tubulocystic carcinoma is a well-circumscribed tumor. Grossly,
it is usually cystic and lacks hemorrhage or necrosis. Some tumors
have a “bubble-wrap”, “Swiss cheese”, or spongy appearance of the
cut surface. Microscopically, the tumor is composed of tubules and
cystic structures of markedly variable sizes, separated by delicate
septa. Tubules are lined with a single layer of cuboidal epithelial
cells with eosinophilic cytoplasm, round nuclei, and characteristi-
cally prominent nucleoli (grade 3) in most cases.
In contrast to the speculation of a collecting duct origin, based
on the immunopositivity for Keratin 34bE12 and Ulex europaeus
agglutinin-1 (UEA-1) reported in the earlier literature, later studies
showed that tubulocystic carcinomas express markers of both
proximal [alpha-methylacyl-conenzyme a racemase (AMACR) and
CD10] and distal nephrons (kidney-speciﬁc cadherin and parval-
bumin). Expressions of cytokeratin 7 (CK), CK19, and 34bE12 are
variable or infrequent. Molecular genetic and expression proﬁling
studies demonstrated evidence against the hypothesis of a collect-
ing duct origin,6,7 but a relationship with papillary renal cell
carcinoma was claimed, especially for frequent gains on chromo-
somes 7 and 17, and loss of the Y chromosome,8 which are hall-
marks of papillary renal cell carcinoma. A case of coexisting
tubulocystic carcinoma and papillary renal cell carcinoma was also
reported.10
The differential diagnosis includes benign simple cortical cysts,
cystic nephromas, multilocular cystic renal cell carcinoma, and
mixed epithelial and stromal tumors of the kidney. A simple
cortical cyst is not multilocular and is lined with epithelial cells
similar to those of normal renal tubules. Cystic nephromas are
composed of multilocular cysts lined with ﬂat or attenuated cells.
Multilocular cystic renal cell carcinoma has cysts lined with clear
cells similar to those seen with clear cell renal carcinomas. Neither
cystic nephromas nor multilocular renal cell carcinomas show the
presence of high nuclear grade tumor cells with abundant eosin-
ophilic cytoplasm and prominent nucleoli. Mixed epithelial andan LLC. Open access under CC BY-NC-ND license.
Fig. 1. Tubulocystic carcinoma manifesting as a large cystic mass. Several mural
nodules are present (arrowhead).
Fig. 2. Typical multicystic pattern.
Fig. 3. Tumor cells characterized by eosinophilic cytoplasm, round nuclei, and prom-
inent nucleoli.
Fig. 4. Tumor involvement with adipose tissues.
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broad septa that may or may not contain ovarian-type stroma,
which is absent from tubulocystic carcinomas.
3. Comment
Currently, the tumor is not listed as a distinct subtype in the
World Health Organization classiﬁcation of renal tumors.11 On the
basis of mixed evidence of proximal and distal nephron differen-
tiation, and a lack of substantial data identifying a speciﬁc cell of
origin, tubulocystic carcinoma may be considered a unique
morphologic entity, until further studies are undertaken to char-
acterize the molecular signature associated with this tumor.
Recently we saw a case of a 45-year-old manwho complained of
ﬂank pain. Our impression was of a renal cyst. He ﬁrst underwent
unrooﬁng of the cyst and later received a radical nephrectomy after
the pathological diagnosis of tubulocystic carcinoma. Unfortunately
local recurrence occurred 2 years after surgery. Grossly, the tumor
was apparently cystic (Fig. 1). However, examination of the mural
nodules revealed a typical histology of tubulocystic carcinoma
(Figs. 2 and 3). An examination of the recurrent lesions showed
a metastatic tumor in adipose tissues (Fig. 4). This unusual case
attests to the malignant nature of the disease, and the malignant
potential of the tumor must be emphasized based on this case
experience.
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